These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47 related articles for article (PubMed ID: 5810137)
1. [Contribution to the toxicity of Neotan]. Müller J; Zajícová P; Sobek V Cas Lek Cesk; 1969 Sep; 108(38):1138-9. PubMed ID: 5810137 [No Abstract] [Full Text] [Related]
2. A salt of orotic acid and neomycin. Sobek V; Král Z Arzneimittelforschung; 1967 Jun; 17(6):711-4. PubMed ID: 5632371 [No Abstract] [Full Text] [Related]
3. Toxicity of neomycin on enzyme activities of kidney and duodenal mucosa in vivo: organ specificity and species difference between rats and mice. Suzuki S; Hatashima S; Shinzawa Y; Niwa O; Tamatani R Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1994 Sep; 109(1):77-92. PubMed ID: 7881811 [TBL] [Abstract][Full Text] [Related]
4. Toxicity of acetylated gentamicin and neomycin. Weinstein MJ; Wagman GH; Taber RI Antimicrob Agents Chemother (Bethesda); 1965; 5():227-31. PubMed ID: 5883432 [No Abstract] [Full Text] [Related]
5. Toxic and vascular nephropathy associated with orotic acid administration in laboratory cats. Dimski DS; Taylor HW; Taboada J; Van Steenhouse JL; Swenson DH; Marx BD Nephron; 1994; 68(2):275-6. PubMed ID: 7830874 [No Abstract] [Full Text] [Related]
6. Alterations of lipoprotein metabolism in orotic acid-induced fatty liver. Roheim PS; Switzer S; Girard A; Eder HA Am J Pharm Sci Support Public Health; 1966 Jan; 15(1 Pt 1):21-6. PubMed ID: 5931986 [No Abstract] [Full Text] [Related]
8. Comparison of the nephrotoxicity of oral neomycin and ampicillin in rats. Narendranathan M; Kurien M; Praseeda I; Balakrishnan V; Varghese S Indian J Gastroenterol; 1982 Apr; 1(1):19-21. PubMed ID: 6927634 [No Abstract] [Full Text] [Related]
9. The potentiating effect of tumors on neomycin toxicity. RENAUD S Arzneimittelforschung; 1960 Aug; 10():566-8. PubMed ID: 13740816 [No Abstract] [Full Text] [Related]
10. Effects of oral administration of orotic acid on hepatic morphologic characteristics and serum biochemical variables in cats. VanSteenhouse JL; Dimski DS; Taylor HW; Swenson DH; Taboada J; Hosgood G Am J Vet Res; 1999 Jun; 60(6):749-52. PubMed ID: 10376906 [TBL] [Abstract][Full Text] [Related]
11. [A contribution to the problem of the toxicity of locally applied neomycin in the therapy of chronic otitis]. KLAUE HH HNO; 1960 Aug; 8():338-41. PubMed ID: 13756570 [No Abstract] [Full Text] [Related]
12. Insulin-like growth factor binding protein (IGFBP)-mediated hair cell survival on the mouse utricle exposed to neomycin: the roles of IGFBP-4 and IGFBP-5. Park JY; Park YH; Shin DH; Oh SH Acta Otolaryngol Suppl; 2007 Oct; (558):22-9. PubMed ID: 17882566 [TBL] [Abstract][Full Text] [Related]
13. Fenofibrate prevents orotic acid--induced hepatic steatosis in rats. Ferreira AV; Parreira GG; Porto LC; Mario EG; Delpuerto HL; Martins AS; Botion LM Life Sci; 2008 Apr; 82(15-16):876-83. PubMed ID: 18374364 [TBL] [Abstract][Full Text] [Related]
14. Effects of uracil mustard on DNA, RNA, and protein biosynthesis in tissues of A-J mice. Abell CW; Rosini LA; DiPaolo JA Cancer Res; 1967 Jun; 27(6):1101-8. PubMed ID: 6027200 [No Abstract] [Full Text] [Related]
15. Clinical and experimental nephropathy resulting from use of neomycin sulfate. EINSPRUCH BC; GONZALEZ VV J Am Med Assoc; 1960 Jun; 173():809-11. PubMed ID: 13819728 [No Abstract] [Full Text] [Related]
16. Prevention of neomycin-induced nephrotoxic event in pig proximal tubular epithelial cell line by apolipoprotein E3. Takamoto K; Kawada M; Ikeda D J Antibiot (Tokyo); 2005 May; 58(5):353-5. PubMed ID: 16060389 [TBL] [Abstract][Full Text] [Related]
17. Further investigations with a view to enhancing the tolerance of streptomycin, viomycin, and neomycin by means of pantothenic acid. KELLER H; KRUPE W; SOUS H; MUCKTER H Antibiot Annu; 1956-1957; ():549-53. PubMed ID: 13425431 [No Abstract] [Full Text] [Related]
18. [Acute toxicity of aversectin C : various routes of administration and dosage forms]. Novik TS; Baru RV; Riabova VA; Chukina SI; Krugliak EB; Mosin VA; Driniaev VA Eksp Klin Farmakol; 2001; 64(2):64-6. PubMed ID: 11548452 [TBL] [Abstract][Full Text] [Related]
19. In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulation. Espada R; Valdespina S; Dea MA; Molero G; Ballesteros MP; Bolás F; Torrado JJ J Antimicrob Chemother; 2008 May; 61(5):1125-31. PubMed ID: 18285313 [TBL] [Abstract][Full Text] [Related]
20. [Orotic acid -- a growth factor for Pasteurella multocida]. Flossmann KD; Höfer M; Erler W; Feist H Z Allg Mikrobiol; 1981; 21(2):85-93. PubMed ID: 7269650 [No Abstract] [Full Text] [Related] [Next] [New Search]